Manish Goel
About Manish Goel
SEBI Registered Investment Adviser • Chartered Accountant
423 Articles Published
Manish Goel is a Chartered Accountant and the Founder of Multibagger Securities Research & Advisory Pvt. Ltd. (SEBI Registered Investment Adviser, INA100007736). A full-time value investor since 2010, he has helped thousands of investors build long-term wealth through quality stock picking and disciplined fundamental analysis.
May 19, 2026
Tom Russo's Capacity to Suffer concept names the rarest corporate trait: management willingness to depress today's reported earnings to fund tomorrow's moat. Illustrated with Titan Biotech FY25 audited markers.
May 18, 2026
Pronin, Lin & Ross's 2002 Stanford research on the meta-bias that hides every other cognitive error — why education makes the blind spot worse, the SEBI F&O data that shows ₹1.81 lakh crore of Indian retail losses for what they really are, the six external-structure counter-measures, and how Titan Biotech's FY25 governance architecture (4 of 11 independent directors, 14 board meetings, CFO/OP at 103%, contingent liabilities down 39.7%) illustrates the institutional version of Munger's iron prescription.
May 18, 2026
How to read the Vigil Mechanism / Whistleblower Policy section of an Indian Annual Report — the three overlapping laws, the five-component checklist, and what Titan Biotech FY25's governance markers illustrate. Educational only — not a buy/sell call.
May 18, 2026
Buffett's four filters — understandable business, favourable economics, able-and-trustworthy management, sensible price — applied step by step to Titan Biotech's FY25 audited numbers, in their canonical sequential order.
